Literature DB >> 20637285

Megalin interacts with APP and the intracellular adapter protein FE65 in neurons.

Ximena Alvira-Botero1, Rocío Pérez-Gonzalez, Carlos Spuch, Teo Vargas, Desiree Antequera, Miguel Garzón, Felix Bermejo-Pareja, Eva Carro.   

Abstract

Increasing evidence has implicated megalin, a low-density lipoprotein receptor-related protein, in the pathogenesis of Alzheimer's disease (AD). In the brain, megalin is expressed in brain capillaries, ependymal cells and choroid plexus, where it participates in the clearance of brain amyloid β-peptide (Aβ) complex. Recently, megalin has also been detected in oligodendrocytes and astrocytes. In this study we demonstrate that megalin is widely distributed in neurons throughout the brain. Additionally, given that FE65 mediates the interaction between the low density lipoprotein receptor-related protein-1 and the amyloid precursor protein (APP) to modulate the rate of APP internalization from the cell surface, we hypothesize that megalin could also interact with APP in neurons. Our results confirm that megalin interacts with APP and FE65, suggesting that these three proteins form a tripartite complex. Moreover, our findings imply that megalin may participate in neurite branching. Taken together, these results indicate that megalin has an important role in Aβ-mediated neurotoxicity, and therefore may be involved in the neurodegenerative processes that occur in AD.
Copyright © 2010. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20637285     DOI: 10.1016/j.mcn.2010.07.005

Source DB:  PubMed          Journal:  Mol Cell Neurosci        ISSN: 1044-7431            Impact factor:   4.314


  26 in total

Review 1.  The role of lipoprotein receptors on the physiological function of APP.

Authors:  Timo Wagner; Claus U Pietrzik
Journal:  Exp Brain Res       Date:  2011-09-23       Impact factor: 1.972

2.  Increased selenoprotein P in choroid plexus and cerebrospinal fluid in Alzheimer's disease brain.

Authors:  Rachel H L H Rueli; Arlene C Parubrub; Andrea S T Dewing; Ann C Hashimoto; Miyoko T Bellinger; Edwin J Weeber; Jane H Uyehara-Lock; Lon R White; Marla J Berry; Frederick P Bellinger
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

Review 3.  APOE in the bullseye of neurodegenerative diseases: impact of the APOE genotype in Alzheimer's disease pathology and brain diseases.

Authors:  Rosalía Fernández-Calle; Sabine C Konings; Javier Frontiñán-Rubio; Juan García-Revilla; Lluís Camprubí-Ferrer; Martina Svensson; Isak Martinson; Antonio Boza-Serrano; José Luís Venero; Henrietta M Nielsen; Gunnar K Gouras; Tomas Deierborg
Journal:  Mol Neurodegener       Date:  2022-09-24       Impact factor: 18.879

4.  Amyloid beta a4 precursor protein-binding family B member 1 (FE65) interactomics revealed synaptic vesicle glycoprotein 2A (SV2A) and sarcoplasmic/endoplasmic reticulum calcium ATPase 2 (SERCA2) as new binding proteins in the human brain.

Authors:  Fabian M Nensa; Martin H D Neumann; Andreas Schrötter; Andre Przyborski; Thomas Mastalski; Sergej Susdalzew; Christina Looβe; Stefan Helling; Fouzi El Magraoui; Ralf Erdmann; Helmut E Meyer; Julian Uszkoreit; Martin Eisenacher; Jaehong Suh; Suzanne Y Guénette; Nelli Röhner; Donat Kögel; Carsten Theiss; Katrin Marcus; Thorsten Müller
Journal:  Mol Cell Proteomics       Date:  2013-11-27       Impact factor: 5.911

5.  Evaluation of chronic lead effects in the blood brain barrier system by DCE-CT.

Authors:  Huiying Gu; Paul R Territo; Scott A Persohn; Amanda A Bedwell; Kierra Eldridge; Rachael Speedy; Zhe Chen; Wei Zheng; Yansheng Du
Journal:  J Trace Elem Med Biol       Date:  2020-09-19       Impact factor: 3.849

6.  Choroid plexus implants rescue Alzheimer's disease-like pathologies by modulating amyloid-β degradation.

Authors:  Marta Bolos; Desireé Antequera; Jesús Aldudo; Henrike Kristen; María Jesús Bullido; Eva Carro
Journal:  Cell Mol Life Sci       Date:  2013-12-17       Impact factor: 9.261

Review 7.  APP Receptor? To Be or Not To Be.

Authors:  Carole Deyts; Gopal Thinakaran; Angèle T Parent
Journal:  Trends Pharmacol Sci       Date:  2016-01-31       Impact factor: 14.819

8.  New insights in the amyloid-Beta interaction with mitochondria.

Authors:  Carlos Spuch; Saida Ortolano; Carmen Navarro
Journal:  J Aging Res       Date:  2012-03-19

9.  LRP-1 and LRP-2 receptors function in the membrane neuron. Trafficking mechanisms and proteolytic processing in Alzheimer's disease.

Authors:  Carlos Spuch; Saida Ortolano; Carmen Navarro
Journal:  Front Physiol       Date:  2012-07-16       Impact factor: 4.566

10.  The amyloid precursor protein intracellular domain-fe65 multiprotein complexes: a challenge to the amyloid hypothesis for Alzheimer's disease?

Authors:  Daniel A Bórquez; Christian González-Billault
Journal:  Int J Alzheimers Dis       Date:  2012-02-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.